Foreign accent syndrome and other neuropsychological sequelae of a parieto-occipital lesion following COVID-19 associated posterior reversible encephalopathy syndrome

被引:1
|
作者
Hill, Geoff [1 ]
Archibald, Neil [2 ]
Larkin, Poppy [3 ]
Farquhar, Jenny [4 ]
Evans, Jonathan [5 ]
机构
[1] South Tees Hosp NHS Fdn Trust, Med Psychol Serv, Neuropsychol, Middlesbrough, Cleveland, England
[2] South Tees Hosp NHS Fdn Trust, Neurol, Middlesbrough, Cleveland, England
[3] South Tees Hosp NHS Fdn Trust, Speech & Language Therapy, Middlesbrough, Cleveland, England
[4] South Tees Hosp NHS Fdn Trust, Neurophysiotherapy, Middlesbrough, Cleveland, England
[5] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
关键词
Posterior reversible encephalopathy syndrome; foreign accent syndrome; COVID-19; acalculia; acquired brain injury;
D O I
10.1080/13854046.2022.2108903
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective We describe a previously fit and well 54-year-old female who acquired a range of severe and persisting neuropsychological impairments following a posterior reversible encephalopathy syndrome (PRES) complication of COVID-19. The initial presentation included aphasia, a neurogenic foreign accent syndrome (FAS) and a persisting complete cortical blindness from the underpinning parieto-occipital brain injury. Method Neuropsychological single clinical case report. Results The patient retained insight and made good early progress with their adjustment to the numerous losses caused by the COVID-19 associated acquired brain injury. Comprehensive neuropsychological investigation characterised an acalculia, along with deficits in focused, sustained and divided attention impacting on verbal memory, working memory and executive functioning, amongst numerous relative strengths. Conclusion Similar to PRES from other aetiologies, COVID-19 associated PRES can in some cases cause irreversible acquired brain injury. The diverse neuropsychological effects need to be comprehensively investigated and managed. This case adds to the neuropsychological literature on PRES, FAS and acquired brain injury as a rare complication of SARS-CoV-2.
引用
收藏
页码:1321 / 1335
页数:15
相关论文
共 46 条
  • [31] Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome
    Yang, Qing
    Chang, Can-can
    Liu, Mengxiao
    Yu, Yong-qiang
    BMC MEDICAL IMAGING, 2019, 19 (1)
  • [32] Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis
    Bonura, Adriano
    Iaccarino, Gianmarco
    Rossi, Sergio Soeren
    Capone, Fioravante
    Motolese, Francesco
    Calandrelli, Rosalinda
    Di Lazzaro, Vincenzo
    Pilato, Fabio
    JOURNAL OF NEUROLOGY, 2023, 270 (06) : 2826 - 2852
  • [33] Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis
    Adriano Bonura
    Gianmarco Iaccarino
    Sergio Soeren Rossi
    Fioravante Capone
    Francesco Motolese
    Rosalinda Calandrelli
    Vincenzo Di Lazzaro
    Fabio Pilato
    Journal of Neurology, 2023, 270 : 2826 - 2852
  • [34] Posterior reversible encephalopathy syndrome associated with mild COVID-19 infection in a 9-year-old child: A case report and literature review
    Sano, Hitomi
    Yamazaki, Takeshi
    Kudo, Eriko
    Hatakeyama, Kinya
    Ito, Tomoshiro
    IDCASES, 2023, 31
  • [35] Cytokine release syndrome-associated encephalopathy in patients with COVID-19
    Perrin, P.
    Collongues, N.
    Baloglu, S.
    Bedo, D.
    Bassand, X.
    Lavaux, T.
    Gautier-Vargas, G.
    Keller, N.
    Kremer, S.
    Fafi-Kremer, S.
    Moulin, B.
    Benotmane, I.
    Caillard, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (01) : 248 - 258
  • [36] Connective tissue disease is associated with the risk of posterior reversible encephalopathy syndrome following lung transplantation in Korea
    Kim, Tae Jung
    Lee, Hyun Joo
    Park, Samina
    Ko, Sang-Bae
    Park, Soo-Hyun
    Yoon, Seung Hwan
    Na, Kwon Joong
    Park, In Kyu
    Kang, Chang Hyun
    Kim, Young Tae
    Choi, Sun Mi
    Park, Jimyung
    Kim, Joong-Yub
    Lee, Hong Yeul
    ACUTE AND CRITICAL CARE, 2025, 40 (01) : 79 - 86
  • [37] COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin
    Mansoor, Tarab
    Alsarah, Ali A.
    Mousavi, Hossein
    Eliyas, Javed Khader
    Girotra, Tarun
    Hussein, Omar
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (07)
  • [38] SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review
    Wang, Lishen
    Wang, Zhihan
    Huang, Rui
    Li, Weishuai
    Zheng, Dongming
    MEDICINE, 2024, 103 (05) : E37192
  • [39] The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19
    Gomez-Moyano, Elisabeth
    Pavon-Moron, Javier
    Rodriguez-Capitan, Jorge
    Bardan-Rebollar, Daniel
    Ramos-Carrera, Teresa
    Villalobos-Sanchez, Aurora
    de Pedro, Ivan Perez
    Ruiz-Garcia, Francisco J.
    Mora-Robles, Javier
    Lopez-Sampalo, Almudena
    Perez-Velasco, Miguel A.
    Bernal-Lopez, Maria-Rosa
    Gomez-Huelgas, Ricardo
    Jimenez-Navarro, Manuel
    Romero-Cuevas, Miguel
    Costa, Francesco
    Trenas, Alicia
    Perez-Belmonte, Luis M.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [40] The first case of hemorrhagic shock and encephalopathy syndrome with fulminant hypercytokinemia associated with pediatric COVID-19
    Kurane, Koyuru
    Wakae, Keizo
    Yamagishi, Hirokazu
    Kawahara, Yuta
    Ono, Marika
    Tamura, Daisuke
    Furuya, Kaito
    Taga, Naoyuki
    Matsuki, Mitsuru
    Yamagata, Takanori
    Muramatsu, Kazuhiro
    BRAIN & DEVELOPMENT, 2024, 46 (01) : 44 - 48